Masked hypertension—what lies ahead?

[1] Pickering TG(2002)Masked hypertension Hypertension 40 795-796

[2] Davidson K(2014)Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions J Hum Hypertens 28 521-528

[3] Gerin W(2013)European Society of Hypertension position paper on ambulatory blood pressure monitoring J Hypertens 31 1731-1768

[4] Schwartz JE(2011)Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis Am J Hypertens 24 52-58

[5] Peacock J(2015)Masked hypertension: a phenomenon of measurement Hypertension 65 16-20

[6] Diaz KM(2013)2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 1281-1357

[7] Viera AJ(2016)Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the jackson heart study Hypertension 68 501-510

[8] Schwartz JE(2015)Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review Ann Intern Med 163 691-700

[9] Shimbo D(2016)Prevalence of masked hypertension and its association with subclinical cardiovascular disease in African Americans: results from the jackson heart study J Am Heart Assoc 4 e002284-778

[10] O'Brien E(2005)Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens 18 772-542

[1] Pickering TG(2002)Masked hypertension Hypertension 40 795-796

[2] Davidson K(2014)Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions J Hum Hypertens 28 521-528

[3] Gerin W(2013)European Society of Hypertension position paper on ambulatory blood pressure monitoring J Hypertens 31 1731-1768

[4] Schwartz JE(2011)Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis Am J Hypertens 24 52-58

[5] Peacock J(2015)Masked hypertension: a phenomenon of measurement Hypertension 65 16-20

[6] Diaz KM(2013)2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 1281-1357

[7] Viera AJ(2016)Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the jackson heart study Hypertension 68 501-510

[8] Schwartz JE(2015)Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review Ann Intern Med 163 691-700

[9] Shimbo D(2016)Prevalence of masked hypertension and its association with subclinical cardiovascular disease in African Americans: results from the jackson heart study J Am Heart Assoc 4 e002284-778

[10] O'Brien E(2005)Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens 18 772-542